Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Neurocrine Biosciences (NBIX) over the last 15 years, with Q4 2025 value amounting to $1.48.

  • Neurocrine Biosciences' EPS (Weighted Average and Diluted) rose 4800.0% to $1.48 in Q4 2025 from the same period last year, while for Dec 2025 it was $4.66, marking a year-over-year increase of 4164.13%. This contributed to the annual value of $4.67 for FY2025, which is 4194.53% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported EPS (Weighted Average and Diluted) of $1.48 as of Q4 2025, which was up 4800.0% from $2.04 recorded in Q3 2025.
  • In the past 5 years, Neurocrine Biosciences' EPS (Weighted Average and Diluted) registered a high of $2.04 during Q3 2025, and its lowest value of -$0.79 during Q1 2023.
  • In the last 4 years, Neurocrine Biosciences' EPS (Weighted Average and Diluted) had a median value of $0.82 in 2023 and averaged $0.76.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 15316.46% in 2024, then plummeted by 8095.24% in 2025.
  • Over the past 4 years, Neurocrine Biosciences' EPS (Weighted Average and Diluted) (Quarter) stood at $0.23 in 2021, then surged by 534.78% to $1.46 in 2023, then crashed by 31.51% to $1.0 in 2024, then surged by 48.0% to $1.48 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $1.48 for Q4 2025, versus $2.04 for Q3 2025 and $1.06 for Q2 2025.